- |
- Share
Bradley Peterson, M.D.
Director of the Center for Developmental Neuropsychiatry
Director of the Center for Developmental Neuropsychiatry,
New York State Psychiatric Institute
Suzanne Crosby Murphy Professor in Pediatric Neuropsychiatry,
Columbia University
Dr. Peterson Directs the Center for Developmental Neuropsychiatry in the Department of Psychiatry at Columbia University. His research and clinical interests include understanding the causes and treatments of serious developmental neuropsychiatric disorders, such as Tourette syndrome, Obsessive-Compulsive Disorder, Attention-Deficit/Hyperactivity Disorder, Bipolar Disorder, and Autism.
His research studies typically aim to integrate anatomical and functional MRI data with behavioral, neuropsychological, biological, and symptom measures in large samples of participating children and adults.
Education and Training
Undergraduate: Tulane University, 1983
Medical School: University of Wisconsin-Madison, M.D., 1987
Internship: University of Wisconsin-Madison, Internal Medicine, 1987 - 1988
Residency: Massachusetts General Hospital, General Psychiatry, 1988 - 1990
Fellowship: Yale Child Study Center, Postdoctoral Research, 1990 - 1992
Post-Graduate: Yale Child Study Center, Child Psychiatry, 1992 - 1994
Board Certifications: American Board of Psychiatry and Neurology
Subspeciality Certifications: Child & Adolescent Psychiatry
Specialties
• Tourette Syndrome
• Obsessive-Compulsive Disorders
• Autism
Click here for Dr. Peterson's Clinical Trials
Contact information
Address:
NYS Psychiatric Institute
Room 5214 Unit/Box:74
1051 Riverside Drive
New York, NY 10032
Phone: 212-543-5330
Fax: 212-543-5966
PetersoB@nyspi.columbia.edu
Personal Homepage
research summary
His research interests concern primarily the applications of neuroimaging to the study of serious developmental neuropsychiatric disorders, including Tourette syndrome, ADHD, OCD, Autism, Bipolar Disorder, Depression, prenatal toxin exposure, and premature birth. His imaging studies integrate measures of brain structure and function with genetic, neurochemical, behavioral, neuropsychological, and clinical measures to define disease processes and therapeutic responses in large samples of children and adults. He is using neuroimaging techniques to study the effects on brain structure and function of various treatment modalities, including psychoanalysis, psychodynamically oriented psychotherapies, behavioral therapies, and medication.
Publications
